- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/14 - Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Patent holdings for IPC class A61P 25/14
Total number of patents in this class: 1731
10-year publication summary
|
70
|
80
|
125
|
158
|
151
|
142
|
167
|
147
|
124
|
45
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2703 |
33 |
| Taisho Pharmaceutical Co., Ltd. | 859 |
31 |
| Auspex Pharmaceuticals, Inc. | 187 |
26 |
| Neurocrine Biosciences, Inc. | 400 |
23 |
| Daiichi Sankyo Company, Limited | 1849 |
20 |
| Sage Therapeutics, Inc. | 361 |
18 |
| Kyoto University | 2790 |
17 |
| Prilenia Neurotherapeutics Ltd. | 85 |
15 |
| The Regents of the University of California | 19803 |
13 |
| PTC Therapeutics, Inc. | 479 |
13 |
| Sumitomo Dainippon Pharma Co., Ltd. | 216 |
13 |
| Vanderbilt University | 1886 |
13 |
| Adeptio Pharmaceuticals Limited | 21 |
13 |
| F. Hoffmann-La Roche AG | 7920 |
12 |
| Voyager Therapeutics, Inc. | 246 |
12 |
| Ovid Therapeutics Inc | 154 |
11 |
| Shionogi & Co., Ltd. | 868 |
11 |
| Sumitomo Pharma Co., Ltd. | 619 |
11 |
| Duke University | 3056 |
10 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 820 |
10 |
| Other owners | 1406 |